Ontology highlight
ABSTRACT: Background
Adalimumab-aqvh/CHS-1420 (YUSIMRYTM) (hereafter referred to as adalimumab-aqvh) was recently approved by the US Food and Drug Administration as a biosimilar for adalimumab.Objective
The current study was conducted to investigate the analytical similarity of adalimumab-aqvh and the reference product, adalimumab.Methods
The structural, functional, and stability attributes of adalimumab-aqvh and adalimumab were compared using state-of-the-art assays. The primary structure, disulfide structure, glycan profile, secondary and tertiary structures, molar mass, size variants, free thiol, charge variants, hydrophobic variants, post-translational modifications, subvisible particles, host cell proteins, and protein concentration were investigated. The func
SUBMITTER: Jiang Y
PROVIDER: S-EPMC10676336 | biostudies-literature | 2023 Dec
REPOSITORIES: biostudies-literature